|

Irinotecan Sucrosofate Clinical Trials

2 actively recruiting trials across 2 locations

Also known as: Irinotecan Liposome, Irinotecan Sucrosofate Liposome, Irinotecan Sucrosofate-containing Pegylated Liposomal Formulation, MM 398, MM-398 +10 more

Pipeline

Phase 3: 2

Top Sponsors

  • SWOG Cancer Research Network1
  • NRG Oncology1

Indications

  • Stage IV Pancreatic Cancer AJCC v82
  • Stage III Pancreatic Cancer AJCC v82
  • Cancer2
  • Unresectable Pancreatic Adenocarcinoma1
  • Metastatic Pancreatic Adenocarcinoma1

Anchorage, Alaska1 trial

Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations

Anchorage Associates in Radiation Medicine

Phase 3

Gilbert, Arizona1 trial

Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer

Banner MD Anderson Cancer Center

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.